Trial site
Universitaetsklinikum Tuebingen AöR
- 314running trials
- 109closed trials
The trials here
What the 427 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers41 trials
- Multiple myeloma32 trials
- Melanoma23 trials
- Lung cancer19 trials
- Acute lymphoblastic leukaemia15 trials
- Metastatic breast cancer15 trials
- Prostate cancer15 trials
- Liver and biliary tract cancer14 trials
- Bladder cancer12 trials
- Macular degeneration12 trials
- Multiple sclerosis12 trials
- Atopic dermatitis (eczema)11 trials
- and 82 more
- Phase
- Phase 3240 trials
- Phase 298 trials
- Phase 1/231 trials
- Phase 130 trials
- Phase 2/320 trials
- Phase 48 trials
- Status
- Recruiting154 trials
- Active, not recruiting129 trials
- Completed109 trials
- Not yet recruiting31 trials
- Suspended4 trials
- Lead sponsor
- Hoffmann-La Roche23 trials
- Merck Sharp & Dohme LLC21 trials
- Janssen Research & Development, LLC17 trials
- AstraZeneca15 trials
- University Hospital Tuebingen13 trials
- and 202 more
Running trials
Not yet recruiting
Not yet recruiting
An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
Recruiting
Not yet recruiting
Not yet recruiting
A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
Recruiting
Recruiting
Not yet recruiting
A Phase 1/2/3 Study of ATSN-201 Gene Therapy in Subjects with RS1-Associated X linked Retinoschisis
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Not yet recruiting
Cangrelor safety and pharmacodynamics in paediatric subjects with congenital heart disease
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Recruiting
Recruiting
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Recruiting
Recruiting
Recruiting
Recruiting
Showing 50 of 314.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers25 recruiting
- Lung cancer13 recruiting
- Acute lymphoblastic leukaemia9 recruiting
- Multiple myeloma9 recruiting
- Liver and biliary tract cancer7 recruiting
- Prostate cancer7 recruiting
- Stroke7 recruiting
- Acute myeloid leukaemia6 recruiting
- Melanoma6 recruiting
- Metastatic breast cancer6 recruiting
- Sarcoma6 recruiting
- Ulcerative colitis6 recruiting
- Lupus (SLE)5 recruiting
- Macular degeneration5 recruiting
- Parkinson disease5 recruiting
- Atopic dermatitis (eczema)4 recruiting
- Bladder cancer4 recruiting
- Chronic lymphocytic leukaemia4 recruiting
- Diffuse large B-cell lymphoma4 recruiting
- Epilepsy4 recruiting
- Huntington's disease4 recruiting
- Neuroblastoma4 recruiting
- Systemic sclerosis (scleroderma)4 recruiting
- Triple-negative breast cancer4 recruiting
- Atrial fibrillation3 recruiting
- Crohn's disease3 recruiting
- Dermatomyositis and polymyositis (myositis)3 recruiting
- Head and neck cancer3 recruiting
- Heart failure3 recruiting
- Immune thrombocytopenia (ITP)3 recruiting
- Multiple sclerosis3 recruiting
- Myelodysplastic syndromes3 recruiting
- Ovarian cancer3 recruiting
- Antiphospholipid syndrome2 recruiting
- Chronic spontaneous urticaria2 recruiting
- Endometrial cancer2 recruiting
- Follicular lymphoma2 recruiting
- Hidradenitis suppurativa2 recruiting
- Kidney cancer2 recruiting
- Pancreatic cancer2 recruiting
- Psoriatic arthritis2 recruiting
- Retinitis pigmentosa2 recruiting
- Vitiligo2 recruiting
- Alzheimer disease1 recruiting
- ANCA-associated vasculitis1 recruiting
- Ankylosing spondylitis1 recruiting
- Burkitt lymphoma1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Coeliac disease1 recruiting
- Colorectal cancer1 recruiting
- Congenital heart disease1 recruiting
- Cytomegalovirus infection1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Depression1 recruiting
- Diabetic eye disease1 recruiting
- Dystonia1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Friedreich ataxia1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Glioblastoma1 recruiting
- Hearing loss1 recruiting
- HIV1 recruiting
- Lichen planus1 recruiting
- Liver cirrhosis1 recruiting
- Neuroendocrine tumours1 recruiting
- Psoriasis1 recruiting
- Rheumatoid arthritis1 recruiting
- Sickle cell disease1 recruiting
- Sjögren's disease1 recruiting
- Thalassaemia1 recruiting
- Turner syndrome1 recruiting
- Type 2 diabetes1 recruiting
- Vascular dementia1 recruiting
Closed trials
Active, not recruiting
Active, not recruiting
Completed
Antimalarial prophylactic efficacy of a weekly dose atovaquone-proguanil
Completed
Completed
A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis
Active, not recruiting
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases
Completed
A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Completed
Completed
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Study of IMG-007 in Participants with Moderate to Severe Atopic Dermatitis
Terminated
A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
Recruiting
Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma
Completed
Completed
Active, not recruiting
Completed
Completed
Efficacy and Tolerability of AP707 in Patients with chronic Pain due to Diabetic Polyneuropathy
Completed
Completed
Completed
Completed
Completed
BPL-003 Efficacy and Safety in Treatment Resistant Depression
Active, not recruiting
Completed
Completed
Active, not recruiting
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
Completed
Completed
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
Completed
Completed
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Completed
Completed
Showing 50 of 109.
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026